🔎 Trials Near Me

Akèy › Pwostat Gwo (BPH)

Etid klinik pou Pwostat Gwo (BPH) ap rekrite nan Etazini

25 etid pou Pwostat Gwo (BPH) ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Post-Market Study to Assess iTind Safety in Comparison to UroLift

Ap rekrite
Laj 50 ak plis · Gason · Mizajou Sep 29, 2026 · NCT04757116

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Ap rekriteVolontè an sante akeyi
Laj 50 a 99 · Gason · Mizajou Sep 29, 2026 · NCT05148156

Ambulatory Long Length URodynamics Evaluation

Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07425015

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06511141

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Sep 8, 2026 · NCT03354416

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Gason · Mizajou Aug 24, 2026 · NCT05898932

Ejaculatory-Sparing HoLEP vs Standard HoLEP

Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Gason · Mizajou Aug 20, 2026 · NCT07631286

Sonablate HIFU International Registry for PC & BPH Patients

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Aug 13, 2026 · NCT07757490

BPH Global Registry

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Aug 13, 2026 · NCT05543200

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

Ap rekriteFaz 2
Laj 18 a 120 · Gason · Mizajou Jul 24, 2026 · NCT06161506

Effect of Group Preoperative Pelvic Floor Training for HoLEP

Ap rekriteEtid obsèvasyon
Laj 50 a 90 · Gason · Mizajou Jul 17, 2026 · NCT05719220

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Ap rekrite
Laj 50 ak plis · Gason · Mizajou Jul 10, 2026 · NCT06312722

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Gason · Mizajou Jun 8, 2026 · NCT07632742

New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Mar 23, 2026 · NCT06944145

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Gason · Mizajou Feb 5, 2026 · NCT07016620

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

Ap rekrite
Laj 18 ak plis · Gason · Mizajou Nov 6, 2025 · NCT07071207

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Ap rekrite
Laj 50 ak plis · Gason · Mizajou Oct 28, 2025 · NCT04288427

PRescription Exercise for Older Men With Urinary Disease

Ap rekrite
Laj 60 ak plis · Gason · Mizajou Mar 17, 2025 · NCT06225479

Effects of TNF Blockade on Human BPH/LUTS

Ap rekriteFaz 2
Laj 45 a 80 · Gason · Mizajou Nov 21, 2024 · NCT06062875

Customized TULSA-PRO Ablation Registry

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Nov 6, 2024 · NCT05001477

Prostate Single Port & Laser Enucleation Comparison Trial

Ap rekrite
Laj 18 a 88 · Gason · Mizajou May 16, 2024 · NCT06224218

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.